{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:25:37Z","timestamp":1790763937788,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Treatment failure during venom immunotherapy (\n                      <jats:styled-content style=\"fixed-case\">VIT<\/jats:styled-content>\n                      ) may be associated with a variety of risk factors, of which the relative importance is unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Our aim was to evaluate the association of baseline serum tryptase concentration (\n                      <jats:styled-content style=\"fixed-case\">BTC<\/jats:styled-content>\n                      ), mastocytosis in the skin (\n                      <jats:styled-content style=\"fixed-case\">MIS<\/jats:styled-content>\n                      ) and of other parameters with the frequency of objective systemic reactions during in\u2010hospital sting challenge (\n                      <jats:styled-content style=\"fixed-case\">SC<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this observational retrospective study, we enrolled 1532 patients (1609 cases due to double\n                      <jats:styled-content style=\"fixed-case\">SC<\/jats:styled-content>\n                      ) with established honeybee or vespid venom allergy who had undergone\n                      <jats:styled-content style=\"fixed-case\">VIT<\/jats:styled-content>\n                      and a subsequent\n                      <jats:styled-content style=\"fixed-case\">SC<\/jats:styled-content>\n                      . Data were collected on various putative risk factors. Adult\u2010onset\n                      <jats:styled-content style=\"fixed-case\">MIS<\/jats:styled-content>\n                      and\/or a\n                      <jats:styled-content style=\"fixed-case\">BTC<\/jats:styled-content>\n                      \u00a0&gt;\u00a020.0\u00a0\u03bcg\/L was defined as clinical indicators of systemic mastocytosis. Relative rates were calculated with logistic regression models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ninety\u2010eight patients (6.4%) presented with\n                      <jats:styled-content style=\"fixed-case\">MIS<\/jats:styled-content>\n                      and\/or\n                      <jats:styled-content style=\"fixed-case\">BTC<\/jats:styled-content>\n                      \u00a0&gt;\u00a020.0\u00a0\u03bcg\/L. 104 cases (6.5%) developed objective generalized symptoms during\n                      <jats:styled-content style=\"fixed-case\">SC<\/jats:styled-content>\n                      . In the absence of\n                      <jats:styled-content style=\"fixed-case\">MIS<\/jats:styled-content>\n                      , a\n                      <jats:styled-content style=\"fixed-case\">BTC<\/jats:styled-content>\n                      \u00a0\u2264\u00a020\u00a0\u03bcg\/L did not increase the risk for\n                      <jats:styled-content style=\"fixed-case\">VIT<\/jats:styled-content>\n                      failure. The most important factors associated with a worse outcome were\n                      <jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>\n                      inhibitor medication (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      5.24, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.83\u201313.00,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001), honeybee venom allergy (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      5.09, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      3.17\u20138.15,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001), systemic allergic reaction during\n                      <jats:styled-content style=\"fixed-case\">VIT<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      3.07, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.79\u20135.14,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001), and a substantial likelihood to suffer from\n                      <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      2.74, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.37\u20135.22,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.003), whereas a double\n                      <jats:styled-content style=\"fixed-case\">VIT<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      0.51, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      0.27\u20130.90,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.027) and a longer duration of therapy (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      0.68 per treatment month, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      0.50\u20130.93,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.017) reduced the failure rate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The magnitude of therapeutic success correlates with type of venom, duration of therapy, and venom dose. Adult\u2010onset\n                      <jats:styled-content style=\"fixed-case\">MIS<\/jats:styled-content>\n                      and\/or a\n                      <jats:styled-content style=\"fixed-case\">BTC<\/jats:styled-content>\n                      \u00a0&gt;\u00a020\u00a0\u03bcg\/L is a significant, albeit not the strongest determinant for\n                      <jats:styled-content style=\"fixed-case\">VIT<\/jats:styled-content>\n                      failure. According to its odds ratio,\n                      <jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>\n                      inhibitor therapy appears to be associated with the highest risk for\n                      <jats:styled-content style=\"fixed-case\">VIT<\/jats:styled-content>\n                      failure.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cea.12275","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T03:03:08Z","timestamp":1390359788000},"page":"736-746","source":"Crossref","is-referenced-by-count":123,"title":["Predictors of clinical effectiveness of\n                    <scp>H<\/scp>\n                    ymenoptera venom immunotherapy"],"prefix":"10.1111","volume":"44","author":[{"given":"F.","family":"Ru\u00ebff","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"},{"name":"Department of Allergology University of Groningen University Medical Center Groningen RB Groningen the Netherlands"},{"name":"GRIAC research institute University of Groningen University Medical Center Groningen AV Groningen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Oude Elberink","sequence":"additional","affiliation":[{"name":"Department of Allergology University of Groningen University Medical Center Groningen RB Groningen the Netherlands"},{"name":"GRIAC research institute University of Groningen University Medical Center Groningen AV Groningen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bender","sequence":"additional","affiliation":[{"name":"Statistical Consulting Unit Department of Statistics Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chatelain","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"},{"name":"Fakult\u00e4t f\u00fcr Gesundheit der Universit\u00e4t Witten\/Herdecke Witten Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dugas\u2010Breit","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.\u2010P.","family":"Horny","sequence":"additional","affiliation":[{"name":"Department of Pathology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"K\u00fcchenhoff","sequence":"additional","affiliation":[{"name":"Statistical Consulting Unit Department of Statistics Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Linhardt","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mastnik","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sotlar","sequence":"additional","affiliation":[{"name":"Department of Pathology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Stretz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vollrath","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Przybilla","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Flaig","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,16]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16120","article-title":"A systematic review of the clinical effectiveness and cost\u2010effectiveness of Pharmalgen\u00ae for the treatment of bee and wasp venom allergy","volume":"16","author":"Hockenhull J","year":"2012","journal-title":"Health Technol Assess"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.01.025"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00960.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03788.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02118.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.117"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000328760"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32833b280c"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000323763"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.11.44"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063233"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1996.tb04596.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.025"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91953-5"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.08.027"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03436.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03647-3"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.all.0000235903.10548.63"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947809"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00963.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01807.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00038-8"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1201\/9781420010404","volume-title":"Generalized additive models","author":"Wood SN","year":"2006"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1109\/TAC.1974.1100705"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2010.02470.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.11.018"},{"key":"e_1_2_9_28_1","first-page":"65","article-title":"Basal serum tryptase level correlates with severity of hymenoptera sting and age","volume":"17","author":"Kucharewicz I","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2003.01755.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.119154"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(81)90082-8"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(92)90319-W"},{"key":"e_1_2_9_33_1","first-page":"63","article-title":"Systemic reactions during maintenance immunotherapy with honey bee venom","volume":"61","author":"Bousquet J","year":"1988","journal-title":"Ann Allergy"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32833bcf91"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02686.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.04.029"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.03.024"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70239-8"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.11.010"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcea.12275","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cea.12275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:31:53Z","timestamp":1696289513000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.12275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,16]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1111\/cea.12275"],"URL":"https:\/\/doi.org\/10.1111\/cea.12275","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,16]]}}}